J. Schwarz

533 total citations
9 papers, 308 citations indexed

About

J. Schwarz is a scholar working on Molecular Biology, Oncology and Reproductive Medicine. According to data from OpenAlex, J. Schwarz has authored 9 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Reproductive Medicine. Recurrent topics in J. Schwarz's work include Cancer-related Molecular Pathways (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and RNA modifications and cancer (2 papers). J. Schwarz is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and RNA modifications and cancer (2 papers). J. Schwarz collaborates with scholars based in Germany, Switzerland and Peru. J. Schwarz's co-authors include Sven� Mahner, F. Jänicke, Karin Milde‐Langosch, Linn Wölber, Sibyll Hein, Fritz Jaenicke, Ronald Simon, Carsten Bokemeyer, Guido Sauter and Tim H. Brümmendorf and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

J. Schwarz

9 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Schwarz Germany 7 165 71 69 61 60 9 308
Stefanie Schrauwen Belgium 7 135 0.8× 80 1.1× 56 0.8× 97 1.6× 20 0.3× 7 267
Pablo García‐Sanz Spain 11 272 1.6× 85 1.2× 63 0.9× 62 1.0× 32 0.5× 12 387
Patricia Evans United Kingdom 4 97 0.6× 69 1.0× 22 0.3× 57 0.9× 57 0.9× 7 292
Jian Gu China 10 167 1.0× 61 0.9× 54 0.8× 71 1.2× 78 1.3× 20 310
Monica Dandapani United States 7 200 1.2× 154 2.2× 41 0.6× 97 1.6× 28 0.5× 14 396
Véronique Barrès Canada 10 212 1.3× 82 1.2× 59 0.9× 99 1.6× 13 0.2× 19 373
Amelia Paglia Italy 9 144 0.9× 64 0.9× 54 0.8× 129 2.1× 128 2.1× 10 456
Laura M S Seeber Netherlands 7 255 1.5× 147 2.1× 33 0.5× 83 1.4× 34 0.6× 7 368
Yoriko Takahashi Japan 12 283 1.7× 107 1.5× 53 0.8× 62 1.0× 32 0.5× 16 368
Armin Pauer Germany 10 124 0.8× 52 0.7× 28 0.4× 182 3.0× 74 1.2× 14 361

Countries citing papers authored by J. Schwarz

Since Specialization
Citations

This map shows the geographic impact of J. Schwarz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Schwarz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Schwarz more than expected).

Fields of papers citing papers by J. Schwarz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Schwarz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Schwarz. The network helps show where J. Schwarz may publish in the future.

Co-authorship network of co-authors of J. Schwarz

This figure shows the co-authorship network connecting the top 25 collaborators of J. Schwarz. A scholar is included among the top collaborators of J. Schwarz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Schwarz. J. Schwarz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Morante, Zaida, Rossana Ruiz, Gabriel De la Cruz Ku, et al.. (2019). Abstract GS2-05: Impact of the delayed initiation of adjuvant chemotherapy in the outcomes of triple negative breast cancer. Cancer Research. 79(4_Supplement). GS2–5. 4 indexed citations
2.
Schwarz, J., Christine Eulenburg, Christine Blome, et al.. (2011). Health-Related Quality of Life and Patient-Defined Benefit of Clobetasol 0.05% in Women with Chronic Lichen Sclerosus of the Vulva. Dermatology. 223(2). 152–160. 20 indexed citations
3.
Woelber, Linn, Christine zu Eulenburg, Volkmar Mueller, et al.. (2010). Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer. European Journal of Surgical Oncology. 36(6). 583–588. 21 indexed citations
4.
Choschzick, Matthias, Linn Woelber, Christine zu Eulenburg, et al.. (2010). Overexpression of carbonic anhydrase IX (CAIX) in vulvar cancer is associated with tumor progression and development of locoregional lymph node metastases. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 456(5). 483–490. 12 indexed citations
5.
Choschzick, Matthias, Annette Lebeau, Andreas H. Marx, et al.. (2009). Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer. Human Pathology. 41(3). 358–365. 33 indexed citations
6.
Gammal, Alexander T. El, Jozef Zustin, Hendrik Isbarn, et al.. (2009). Chromosome 8p Deletions and 8q Gains are Associated with Tumor Progression and Poor Prognosis in Prostate Cancer. Clinical Cancer Research. 16(1). 56–64. 92 indexed citations
7.
Mahner, Sven�, J. Schwarz, Sibyll Hein, et al.. (2008). C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma. British Journal of Cancer. 99(8). 1269–1275. 107 indexed citations
8.
Mahner, Sven, et al.. (2008). C-Fos Expression as Predictor of Progression and Survival in Epithelial Ovarian Carcinoma. Geburtshilfe und Frauenheilkunde. 68(S 01). 3 indexed citations
9.
Ihnen, Maike, Sven� Mahner, F. Jänicke, & J. Schwarz. (2007). Current treatment options in uterine endometrial stromal sarcoma: report of a case and review of the literature. International Journal of Gynecological Cancer. 17(5). 957–963. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026